T Cells

 

16 Organization(s)

Adaptimmune

Business Area(s): 
Description: 

Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.

Adaptive Biotechnologies

Business Area(s): 
Description: 

T Cell Receptor Analysis

Atara Bio

Business Area(s): 
Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.

AVM Biotechnology

Business Area(s): 
Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.

Bellicum Pharmaceuticals

Business Area(s): 
Description: 

Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...

bluebird bio

Business Area(s): 
Description: 

The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...

CytomX Therapeutics

Business Area(s): 
Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'

Juno Therapeutics

Business Area(s): 
Description: 

The company leverages two technologies—CARs and TCRs—to activate a patient’s own T cells so that they attack cancer cells. Through genetic engineering, we insert a gene for a particular CAR or TCR ...

Lion Biotechnologies

Business Area(s): 
Description: 

Develops tumor-infiltrating T cells designed to overcome the immunosuppressive effects of cancer, while leveraging and enhancing the power of TILs to treat, and potentially cure, all solid tumors ...

NantKwest

Business Area(s): 
Description: 

Develops immunotherapeutics that activate natural killer cells.  

NKT Therapeutics

Business Area(s): 
Description: 

Natural Killer T-Cell Therapeutics

Sorrento Therapeutics

Business Area(s): 
Description: 

Developing novel immunotherapies against medically-relevant targets utilizing Sorrento’s unique portfolio of proprietary OnTarget antibody technologies.  Sorrento is an antibody-centric, clinical ...

TapImmune

Business Area(s): 
Description: 

An immuno-oncology company developing vaccine technologies for the treatment of cancer and infectious disease.

Tempero Pharmaceuticals

Business Area(s): 
Description: 

T Cell Balance Therapies

Vor BioPharma

Business Area(s): 
Description: 

Ziopharm Oncology

Business Area(s): 
Description: 

Employs novel cell engineering techniques and multigenic gene programs to develop next-generation patient- and donor-derived adoptive cellular therapies based on designer cytokines, such as ...